Evidence map›Paper›PMID 35633566›Full record

SynthesisAsian Pacific journal of cancer prevention : APJCP2022

Global Incidence and Trend of Uveal Melanoma from 1943-2015: A Meta-Analysis.

Masood Naseripoor, Fatemeh Azimi, Reza Mirshahi, Golnaz Khakpoor, Asma Poorhosseingholi, Samira Chaibakhsh

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Asian Pacific journal of cancer prevention : APJCP, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Observational
  2. Review
  3. ZEB1 and Uveal Melanoma Invasiveness.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Lack of shared neoantigens in prevalent mutations in cancer.Journal of translational medicine · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Masood NaseripoorIran University of Medical Sciences, Tehran, Iran.
Fatemeh AzimiIran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-9995-0142
Reza MirshahiIran University of Medical Sciences, Tehran, Iran.
Golnaz KhakpoorIran University of Medical Sciences, Tehran, Iran.
Asma PoorhosseingholiShahid Beheshti University of Medical Sciences, Tehran, Iran.
Samira ChaibakhshDepartment of Ophthalmology, Eye Research Center, the Five Senses Institute, Rassoul Akram Hospital, Tehran, Iran.
Iran University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUveal melanoma (UM) is the most common primary intraocular malignancy in adults arising from uveal tissue melanocytes. Considering limited population based studies, we performed a meta-analysis of uveal melanoma incidence rate in worldwide.

methodsFor this meta-analysis, the electronic database of PubMed, Scopus, Embase and Google Scholar were utilized. Qualified Cohort studies and registry system databases were included in the study. Trend analysis and the estimation of incidences were reported. Thereafter subgroup analysis on gender and diagnostic tests were performed. Analyses were done using random effect models.

resultsA total of 22 publications were eligible to include in the meta-analysis. The incidence rates of uveal melanoma were 5.74 (95%CI: 4.37-7.11) and 7.30 (95%CI: 6.36-8.24) in North America and Europe respectively. The analysis showed a significant decreasing trend in North America. It was expected that the risk of UM decreased approximately 0.09 (SE=0.04) per million persons per year. No significant trend was detected in Europe. There was not any significant difference between the incidence rate in male and female (6.58, 95%CI: 5.42-7.75 vs. 5.44, 95%CI: 4.40-6.48). In addition, the reported incidence rates in different diagnostic approaches were similar (6.61, 95%CI: 5.63-7.58 in clinical vs. 6.67, 95%CI: 5.83-7.42 in histological).

conclusionThis analysis confirmed in recent decades, there has been a steady decline in the incidence in North America. However, in European countries where they still have the highest incidence worldwide, the trend was stable. It seems that international melanoma registration collaboration can conduct a unified, multicentral study to estimate the worldwide incidence of UM and impact of different factors on its rate.

Indexed as

MelanomaUveal NeoplasmsAdultFemaleHumansIncidenceMaleRegistriesUveal MelanomaIncidenceMeta-analysisTrenduveal melanoma

Identifiers

PMID35633566
PMCPMC9587874
OpenAlexW4281775272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.